Feed AED.BR
AE

Aedifica SA

AED.BR · BRU

65.95 € +0.23% (+0.15 €)
1M -3.38%
Market Cap 3.29B €
P/E Ratio 5.13x
Div. Yield 4.23%
ROE 12.60%

Bulios Fair Price

95.46 €

44.7% upside

Current Price

65.95 €

Undervalued Fair Value Overvalued

According to Bulios Fair Price, AED.BR is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Weak
2/9
Valuation
94 /100
Cheap
P/S 6.73x
P/B 0.51x
P/E N/A
Growth
51 /100
Stable
EPS growth 16.12%
Book val. growth 3.73%
Rev. growth 10.14%
Profitability
73 /100
Strong
Gross margin 91.73%
FCF margin 0.00%
Net margin 131.13%
Quality
53 /100
Average
ROIC 2.96%
Asset turnover 0.04x
ROE 12.60%
Debt
80 /100
Low
Debt/Equity 0.82x
Debt/Assets 0.40x
Current ratio 0.17x
Stability
65 /100
Moderate
Beta 0.96x
Profitable years 6
Rev. volatility 5.07%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about AED.BR
Online

About the company

Aedifica SA (AED) is a Belgian company specializing in real estate investments in the healthcare sector, particularly in senior housing and long-term care facilities. With a portfolio of properties in Belgium, the Netherlands, Germany, and France, Aedifica SA is one of the leading players in the European healthcare real estate market. The company focuses on long-term leases with fixed rents, providing stable income and long-term value for investors. Investors seeking exponential growth in the healthcare sector and stable long-term investments may find an attractive opportunity in Aedifica SA (AED) shares.

Sector

Real Estate

Industry

REIT - Healthcare Facilities

CEO

Stefaan Gielens

Employees

127

Headquarters

Brussels

Upcoming events

18 NOV

Earnings

Upcoming earnings report

67d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.